Manufacturers increasingly but still infrequently follow Food and Drug Administration guidance that recommends testing pulse oximeters on participants with a range of skin pigmentations, according to ...
Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback